Featured
Last news
Myanmar garment manufacturers warn US tariffs imperil quake recovery
Myanmar's garment manufacturers have warned US tariffs threaten to hobble the country's recovery from a devastating earthquake, as the death toll rose to 3,600.
Mexico mourns photographers killed in music festical mishap
Relatives and friends of two photographers killed in an accident over the weekend at a music festival in Mexico City paid tribute to their lost loved ones on Monday.
US Supreme Court lifts order barring deportations under wartime law
The US Supreme Court on Monday lifted a lower court order barring the deportation of undocumented migrants using an obscure wartime law, in a victory for the Trump administration.
The Dixie Group Reports Financial Results for 2024
DALTON, GA / ACCESS Newswire / April 8, 2025 / You are invited to participate in a conference call with the management of THE DIXIE GROUP, INC (OTCQB:DXYN) regarding results for 2024 Earnings Release on Thursday, April 10, 2025, at 11:00 a.m. Eastern Time.
2025 Inside Self-Storage World Expo Set to Empower and Inspire Industry Professionals, Including Keynote by Champion Wrestler Anthony Robles
ISS World Expo is the leading education and networking event for self-storage owners, managers, developers and investors.
Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis of Substance Use Disorder
Discovery data demonstrates strong sensitivity and specificity in detecting active disease across six different types of substance use disorder
Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show
Exousia Pro has a 60% margin built-in on each order of exosomes
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
Xebra Brands Reaffirms North American Strategy Following U.S. Tariff Clarity
VANCOUVER, BC / ACCESS Newswire / April 8, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the Mexican cannabis sector and the only company legally authorized to import seeds, cultivate, manufacture, operate, and sell cannabis (-1% THC) in Mexico, is reaffirming its strategic commitment to the North American market following new U.S. tariff announcements and amid heightened market fluctuations.
viemaa Launches Innovative BOND SHAMPOO to Indulge, Cleanse, Fortify and Revive Hair
The new shampoo combines natural ingredients and a patented Biomimetic Cuticle Technology in a formula that is scientifically proven to repair damaged hair and make it easier than ever to detangle, smooth and style.
Dolphin to Present at the LD Micro Investor Conference in New York City on April 10, 2025 at 2:00pm ET
MIAMI, FL / ACCESS Newswire / April 8, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, will present at the LD Micro Investor Conference in New York City on April 10, 2025 at 2:00pm ET.
Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
Gelclair® is the company's third commercialized prescription productOral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task forceNapo's core target patient audiences for Gelclair are head and neck cancer patients and bone marrow transplant patients
CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025
TÜBINGEN, DE / ACCESS Newswire / April 8, 2025 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biotech company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results, and provide business updates for the fourth quarter and full-year 2024 on Thursday, April 10, 2025. The company will host a conference call and webcast on the same day at 3 p.m. CET / 9 a.m. EST.
Interactive Strength Inc. (NASDAQ "TRNR") Signs Binding Agreement to Acquire Wattbike, a $15M+, Omni-Channel, Connected, Indoor- Performance-Bike Business
Transaction Expected to Help TRNR Generate More than $65M in 2025 Revenue on a Pro Forma basisWattbike is the Leading, Indoor-Bike Brand for Elite-Athlete Training and is Used by Olympians and Professional Sports Teams Worldwide - Including the NFL, NBA, MLB, NHL and Premier LeagueTRNR Listing, Global Distribution Network to Help Wattbike Accelerate Growth, Especially in Key Markets Like US and Germany; Wattbike's Deep Penetration into Leading UK Gyms and Expanding D2C Customer Base to Similarly Speed Up Step-Changes to TRNR Top and Bottom LinesTransaction Delivers on Previously-Announced LOI, Combines Highly Complementary Businesses to Create a Scaled, International Operation Anchored in the US, Germany and UK, the #1, #2 and #3 Fitness Markets GloballyDeal - Expected to be TRNR's 3rd Within a Year-and-a-Half - Builds on its Transformative Portfolio Strategy for Creating Long-Term Shareholder ValueAcquisition Expected to Close as Early as the Second Quarter of 2025, Subject to Standard Regulatory Requirements
National Health Investors, Inc. Highlights Steps Taken to Deliver Stockholder Value
National Health Investors, Inc. Files Definitive Proxy Materials and Mails Letter to StockholdersNHI Continues Commitment to Board Refreshment with Two Appointments in 2025 and Meaningful Governance EnhancementsNHI Urges Stockholders to Vote "FOR" National Health Investors, Inc.'s Highly Qualified and Experienced Nominees on the WHITE Proxy Card
Federal Probe DEA - MMJ Marijuana Application Drug Development - 7 Years Delayed As HD Patients Suffering
Central to the probe are DEA's Thomas Prevoznik, DEA's Matthew Strait and DEA attorney Aarathi Haig within the DEA's Diversion Control Division, whose conduct has raised serious questions about the integrity of the DEA's regulatory processes.
Inter captain Martinez fined 5,000 euros for blasphemy
Lautaro Martinez has avoided a suspension for blasphemy after the Inter Milan captain agreed a fine with the Italian Football Federation (FIGC) for offensive language during a defeat to arch-rivals Juventus.
Boeing settles to avoid civil trial over Ethiopian Airlines crash
Boeing has reached a last-minute settlement to avoid a civil trial that was due to start Monday over the fatal 2019 crash of an Ethiopian Airlines 737 MAX plane, the plaintiffs' lawyers.
King Charles III shrugs off health scare to begin Italy visit
King Charles III arrives in Italy on Monday for a four-day visit where he will become the first UK monarch to address Italy's joint parliament, but will not meet Pope Francis due to the pontiff's health issues.
Unification Church appeals Japan's decision to revoke legal status
The Unification Church said Monday it had appealed a Japanese court's decision to strip the sect of official recognition, in the wake of the assassination of ex-premier Shinzo Abe.
'Fear and anxiety': Bangkok residents seek quake-proof homes
Shaken hours earlier by a massive earthquake, Phatsakon Kaewkla's terror was magnified when he came home to find gaping cracks in the walls of his 22nd-floor Bangkok apartment.
Haiti jazz festival is rare respite for violence-racked capital
Residents of Haiti's gang-plagued capital could enjoy a brief escape from daily lives scarred with violence this weekend as the PapJazz festival entertained around 100 music fans.
Trail to Tryon Holiday Half in New Bern, NC Unveils New Name, Date and Multiyear Title Sponsor
Signs CRRG Events to a multiyear Event Management agreement
SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations
CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce the formation of a dedicated AI team focused on enhancing the capabilities of the ABBIE (A Binding-based Integrase Enzyme) system and the design of novel guide RNAs and other RNA guided Integrase fusion proteins. This strategic initiative is set to further SOHM's mission of revolutionizing genome editing and cell engineering technologies and expanding the frontiers of genetic research.
Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
BOCA RATON, FL / ACCESS Newswire / April 7, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that it has entered into a standby equity purchase agreement ("Purchase Agreement") with YA II PN, Ltd. ("Yorkville").
Newsmax’s Audience Grows by 50% in Q1 2025
BOCA RATON, FL / ACCESS Newswire / April 7, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") announced today that its total audience is continuing to surge, growing by an eye-popping 50% from last year, according to a Nielsen report out this week.
CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Significant Regulatory Milestone: U.S. FDA cleared IND application for CVHNLC, CureVac's investigational therapy targeting squamous non-small cell lung cancerProprietary Epitopes: CVHNLC encodes novel tumor epitopes identified through proprietary whole genome-based discovery platformEnhanced Combination Therapy: CVHNLC to be tested in combination with pembrolizumab, aiming to amplify targeted anti-tumor immune responsesClinical Progress: Patient treatment anticipated to start in the second half of 2025Pipeline Advancement: IND clearance highlights CureVac's continued oncology pipeline growth, with more candidates planned to enter the clinic in 2026
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), norovirus, and mpox, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Vienna, Austria, from April 11-15, 2025.
DEA Marijuana Enforcers Fail the Law: The DEA Chief Council Attorney Aarathi Haig Not in Good Standing
"This isn't just about paperwork - it's about a pattern of disregard for the law," said Duane Boise CEO MMJ International Holdings. "The DEA can't demand compliance from others while ignoring its own obligations."Aarathi D. Haig, a DEA attorney central to the agency's controversial handling of MMJ Biopharma Cultivation's Bulk Manufacturers cannabis research application, is not in good standing with the New Jersey Bar. A February 2023 letter from the New Jersey Board of Bar Examiners states Haig is ineligible for a Certificate of Good Standing
France's Le Pen slams 'witch hunt' as political ban dominates rival rallies
France's far-right leader Marine Le Pen on Sunday vowed to pursue her presidential ambitions after she was found guilty of embezzlement and banned from standing for office, telling a rally her party is the target of a "witch hunt".
US storms, 'devastating' flooding death toll climbs to 17
Violent storms battering the central-eastern United States have killed at least 17 people, officials said Sunday, with the National Weather Service warning of "devastating" flash flooding.
Zelensky slams US lack of response to Putin truce rejection
Ukrainian President Volodymyr Zelensky on Sunday lamented the lack of a US response to Russia's refusal to sign "a full, unconditional ceasefire" as two people were killed in Moscow's latest aerial bombardment.